The insert provides dosage, indications, contraindications, side effects, storage, and manufacturer details for BoliKangni Terbutaline Sulphate Tablets.
BoliKangni Terbutaline Sulphate Tablets are a bronchodilator indicated for asthma, chronic bronchitis, emphysema and other bronchospastic lung diseases. The product contains the active ingredient terbutaline sulfate (C12H19NO3)2·H2SO4, 2.5 mg per white tablet.
The insert details dosage regimens for adults and children, lists contraindications and precautions, describes common adverse reactions such as tremor and tachycardia, and provides storage instructions, packaging, shelf life, and manufacturer contact information. This manual is written in Chinese.
| Strength | 2.5 mg per tablet |
|---|---|
| Appearance | White tablet |
| Molecular formula | (C12H19NO3)2·H2SO4 |
| Molecular weight | 548.66 |
| Oral bioavailability | 15 ± 6 % |
| Effective plasma concentration | 3 µg/ml |
| Apparent volume of distribution (Vd) | 1.4 ± 0.4 L/kg |
| Shelf life | 36 months |
Adults start with 1.25 mg (half tablet) 2–3 times daily for 1–2 weeks, then may increase to 2.5 mg (one tablet) 3 times daily.
Common reactions include tremor, headache, tachycardia, palpitations, muscle cramps, and low potassium levels.
Management may include activated charcoal, gastric lavage, monitoring vital signs, correcting metabolic abnormalities, and using a selective β‑blocker such as metoprolol if needed.
Store the tablets away from light in a sealed container.